We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Netscientific Plc | LSE:NSCI | London | Ordinary Share | GB00BN4R5Q82 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 63.00 | 61.00 | 65.00 | 63.00 | 63.00 | 63.00 | 15,341 | 07:36:40 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1M | -3.09M | -0.1312 | -4.80 | 14.85M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/7/2020 12:46 | You're not alone if that offers any comfort at all. | investordave | |
30/7/2020 12:27 | Bloody hope so 40% down on this now | catchingmice | |
30/7/2020 11:02 | This is time for the share price to rise as it has dropped too much from its recent spike. | kingston78 | |
30/7/2020 10:44 | down she goes | texaschaser | |
30/7/2020 09:04 | There are thousands of good reasons why you bought this share investordave. I cannot comment on why you chose to pay what you did for this share. TIMING. | escapetohome | |
30/7/2020 09:02 | Can someone remind me why I bought this share please? After the past few days, I'm beginning to wonder. It looks totally unloved at the moment. | investordave | |
29/7/2020 22:38 | PDSB tweeted out great interview with CEO he is quiet and undemonstrative but you can see he is very excited and animated by current opportunity seriously i've seen his videos on cancer vs his videos now on covid i think they've got serious edge on the CD8 T-cells ? Even leading vaccines may be lacking in that | the stigologist | |
29/7/2020 21:10 | pds chat room hotting up for the further news update | formula1187 | |
29/7/2020 15:35 | Buys showing as sells currentlyNeed 15p here to break even after buying at the height of the last riseLOL | catchingmice | |
29/7/2020 15:33 | I thought this was a pump and dump when i bought this at 3p and it went down to 2p Actually the SOTP is c.20p The pump and dump scumbag who 'frauded' me into this is long gone DYOR and you can beat the scum pump and dumpers and derampers | the stigologist | |
29/7/2020 15:25 | It hasn't even been peer reviewed yet. GVHD will also be a major issue to overcome. Don't be so ridiculous with such rumours. Seriously. This is the lowest info pre clinical you can get. Of course if peer reviews are pairings and phase 1 is successful then you are absolutely prime but you're miles away and a significant cost away from that yet. | justaman | |
29/7/2020 15:18 | Wouldn't surprise anyone when you consider when you consider how hugh this could be:Versamune-CoV-2 (PDS0203) generated high levels of robust, long-lasting CD8 (killer) T-cell responses and potent neutralizing antibody responses within 14 days of vaccination | zen12 | |
29/7/2020 15:14 | Where have you seen that there is a potential takeover bid? | bluebird13 | |
29/7/2020 15:14 | Where have you seen that there is a potential takeover bid? | bluebird13 | |
29/7/2020 15:01 | NSCi TAke Over Rumour by Big pharma.Can be multi bagger from here.Depends on offer price.Dyor | 36jay | |
29/7/2020 11:59 | Lets behonest this share is a pump and dump. Always has been. | baz33 | |
29/7/2020 11:29 | Almost perfect double top | volsung | |
29/7/2020 11:27 | from the lse board expecting psd0240 news with brazil colab covid 19 vaccine company states end of july for this news, ????? | formula1187 | |
29/7/2020 10:55 | This will retrace have faith | sharif1987 | |
29/7/2020 10:22 | To be honest the only reason I didn't buy back in at 12 yesterday was that I couldn't get a buy quote | computercoders | |
29/7/2020 10:22 | I bought yesterday at 12.3 and sold at 12.66 glad I did but seriously looking at piling back in now | computercoders | |
29/7/2020 10:19 | Patience..... | k1ngkonggb |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions